Ameriprise Financial Inc Exelixis, Inc. Transaction History

Ameriprise Financial Inc

  • $356 Billion
  • Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 463,311 shares of EXEL stock, worth $21.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
463,311
Previous 933,675 50.38%
Holding current value
$21.2 Million
Previous $31.1 Million 44.98%
% of portfolio
0.0%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$32.38 - $39.16 $15.2 Million - $18.4 Million
-470,364 Reduced 50.38%
463,311 $17.1 Million
Q4 2024

Feb 14, 2025
SELL
$25.39 - $36.46 $16.7 Million - $24 Million
-657,315 Reduced 41.31%
933,675 $31.1 Million
Q3 2024

Nov 14, 2024
BUY
$21.96 - $27.6 $1.79 Million - $2.25 Million
81,414 Added 5.39%
1,590,990 $41.3 Million
Q2 2024

Aug 14, 2024
SELL
$20.34 - $23.73 $7.79 Million - $9.09 Million
-383,097 Reduced 20.24%
1,509,576 $33.9 Million
Q1 2024

May 15, 2024
BUY
$20.17 - $23.93 $678,659 - $805,172
33,647 Added 1.81%
1,892,673 $44.9 Million
Q4 2023

Feb 14, 2024
SELL
$19.25 - $24.13 $7.85 Million - $9.84 Million
-407,906 Reduced 17.99%
1,859,026 $44.6 Million
Q3 2023

Nov 14, 2023
BUY
$19.04 - $22.74 $4.17 Million - $4.97 Million
218,757 Added 10.68%
2,266,932 $49.5 Million
Q2 2023

Aug 14, 2023
SELL
$18.17 - $20.48 $4.25 Million - $4.8 Million
-234,149 Reduced 10.26%
2,048,175 $39.1 Million
Q1 2023

May 15, 2023
SELL
$16.3 - $19.41 $2.21 Million - $2.63 Million
-135,396 Reduced 5.6%
2,282,324 $44.3 Million
Q4 2022

Feb 14, 2023
SELL
$14.96 - $17.39 $1.11 Million - $1.29 Million
-74,385 Reduced 2.98%
2,417,720 $38.8 Million
Q3 2022

Nov 14, 2022
BUY
$15.68 - $22.27 $9.52 Million - $13.5 Million
606,869 Added 32.19%
2,492,105 $39.1 Million
Q2 2022

Aug 15, 2022
SELL
$17.44 - $23.16 $7.86 Million - $10.4 Million
-450,742 Reduced 19.3%
1,885,236 $39.3 Million
Q1 2022

May 16, 2022
BUY
$17.03 - $22.67 $5.97 Million - $7.94 Million
350,437 Added 17.65%
2,335,978 $53 Million
Q4 2021

Feb 14, 2022
BUY
$15.84 - $21.88 $23.7 Million - $32.7 Million
1,496,377 Added 305.9%
1,985,541 $36.3 Million
Q3 2021

Nov 15, 2021
SELL
$16.3 - $21.14 $3.53 Million - $4.57 Million
-216,348 Reduced 30.67%
489,164 $10.3 Million
Q2 2021

Aug 16, 2021
SELL
$17.95 - $25.56 $115,328 - $164,223
-6,425 Reduced 0.9%
705,512 $12.9 Million
Q1 2021

May 17, 2021
SELL
$20.53 - $25.22 $1.68 Million - $2.07 Million
-81,901 Reduced 10.32%
711,937 $16.1 Million
Q4 2020

Feb 12, 2021
BUY
$18.39 - $24.8 $1.27 Million - $1.71 Million
68,796 Added 9.49%
793,838 $15.9 Million
Q3 2020

Nov 16, 2020
SELL
$20.67 - $26.94 $4.32 Million - $5.63 Million
-208,816 Reduced 22.36%
725,042 $17.7 Million
Q2 2020

Aug 14, 2020
BUY
$16.46 - $27.42 $2.62 Million - $4.36 Million
159,170 Added 20.55%
933,858 $22.2 Million
Q1 2020

May 15, 2020
BUY
$14.46 - $21.8 $512,794 - $773,093
35,463 Added 4.8%
774,688 $13.3 Million
Q4 2019

Feb 14, 2020
SELL
$15.15 - $18.89 $1.57 Million - $1.95 Million
-103,330 Reduced 12.26%
739,225 $13 Million
Q3 2019

Nov 14, 2019
SELL
$17.68 - $22.65 $762,715 - $977,120
-43,140 Reduced 4.87%
842,555 $14.9 Million
Q2 2019

Aug 14, 2019
BUY
$18.93 - $24.75 $1.21 Million - $1.58 Million
63,675 Added 7.75%
885,695 $18.9 Million
Q1 2019

May 15, 2019
SELL
$19.6 - $24.76 $95,236 - $120,308
-4,859 Reduced 0.59%
822,020 $19.6 Million
Q4 2018

Feb 14, 2019
SELL
$13.65 - $21.8 $550,586 - $879,324
-40,336 Reduced 4.65%
826,879 $16.3 Million
Q3 2018

Nov 14, 2018
BUY
$15.87 - $22.4 $12.1 Million - $17.1 Million
762,313 Added 726.69%
867,215 $15.4 Million
Q2 2018

Aug 14, 2018
SELL
$18.56 - $22.45 $1.47 Million - $1.78 Million
-79,085 Reduced 42.98%
104,902 $2.26 Million
Q1 2018

May 15, 2018
BUY
$22.15 - $31.89 $614,197 - $884,277
27,729 Added 17.75%
183,987 $4.07 Million
Q4 2017

Feb 12, 2018
BUY
$24.23 - $30.93 $2.01 Million - $2.56 Million
82,812 Added 112.75%
156,258 $4.75 Million
Q3 2017

Nov 07, 2017
BUY
$23.35 - $29.24 $1.71 Million - $2.15 Million
73,446
73,446 $1.78 Million

Others Institutions Holding EXEL

# of Institutions
613
Shares Held
257M
Call Options Held
1.57M
Put Options Held
730K
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $14.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email